Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Recruiting 5Active not recruiting 5Not yet recruiting 3Completed 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Multiple Myeloma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1HER2-positive Breast Cancer 1

Interventions

Specimen Handling 125pembrolizumab 123Magnetic Resonance Spectroscopy 108Carboplatin 89Cyclophosphamide 80Biopsy 69Cisplatin 67Paclitaxel 61Bevacizumab 56Gemcitabine 54Nivolumab 49fludarabine 48Dexamethasone 41Rituximab 39Pemetrexed 39Fluorouracil 39Radiotherapy 37Doxorubicin 37atezolizumab 36Docetaxel 36Leucovorin 35Oxaliplatin 32Capecitabine 32venetoclax 31Temozolomide 29Prednisone 29durvalumab 27Standard of Care 27Radiation 27Letrozole 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Neoadjuvant Therapy × 30 days × Clear all
NCT06290687 2026-06-05

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Case Comprehensive Cancer Center

Phase 2 Recruiting
40 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT07149857 2026-06-05

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting
60 enrolled
Plasma cell

Multiple Myeloma

NCT07616440 2026-06-04

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
20 enrolled
Breast

HER2-positive Breast Cancer

NCT06788912 2026-06-01

MK-3475-01E

Merck Sharp & Dohme LLC

Phase 2 Recruiting
60 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡